Lymphangiogenesis in deep infiltrating endometriosis

Human Reproduction

Volumn 26, Issue 10, 2011, Pages 2713-2720

  Keichel, S ^a   Barcena De Arellano, M L ^a   Reichelt, U ^a   Riedlinger, W F J ^a   Schneider, A ^a   Khler, C ^a   Mechsner, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

deep infiltrating endometriosis; endometriosis; lymph node; Lymphangiogenesis; lymphatic spread

Indexed keywords

LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; PODOPLANIN; PROSPERO HOMEOBOX PROTEIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DEEP INFILTRATING ENDOMETRIOSIS; ENDOMETRIOSIS; EPITHELIUM CELL; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPH VESSEL DENSITY; LYMPHANGIOGENESIS; MESOCOLON; PREMENOPAUSE; PROTEIN EXPRESSION; STROMA CELL; VAGINA;

EID: 80052883293     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der230     Document Type: Article

References (47)

1. Abrao MS, Podgaec S, Dias JA Jr, Averbach M, Garry R, Ferraz Silva LF, Carvalho FM. Deeply infiltrating endometriosis affecting the rectum and lymph nodes. Fertil Steril 2006;3:543-547. (Pubitemid 44307031)
2. Anaf V, Simon P, El Nakadi I, Fayt I, Buxant F, Simonart T, Peny MO, Noel JC. Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod 2000;15:1744-1750. (Pubitemid 30636063)
3. ASRM. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;5:817-821.
4. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;4:789-801. (Pubitemid 29234556)
5. Barrier BF, Dick EJ Jr, Butler SD, Hubbard GB. Endometriosis involving the ileocaecal junction with regional lymph node involvement in the baboon-striking pathological finding identical between the human and the baboon: a case report. Hum Reprod 2007;1:272-274. (Pubitemid 44942696)
6. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999;2:385-394. (Pubitemid 29094089)
7. Bulun SE. Endometriosis. N Engl J Med 2009;3:268-279.
8. Cao Y. Why and how do tumors stimulate lymphangiogenesis? Lymphat Res Biol 2008;3-4:145-148.
9. Chang LK, Garcia-Cardena G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci USA 2004;32:11658-11663. (Pubitemid 39095352)
10. Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 2005;1:143-152. (Pubitemid 40128107)
11. Donnez J, Nisolle M, Smoes P, Gillet N, Beguin S, Casanas-Roux F. Peritoneal endometriosis and 'endometriotic' nodules of the rectovaginal septum are two different entities. Fertil Steril 1996; 3:362-368. (Pubitemid 27009872)
12. Donoghue JF, Lederman FL, Susil BJ, Rogers PA. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 2007;6:1705-1713. (Pubitemid 47055162)
13. Fan YZ, Li GM, Huang GP, Li XP. Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 2006;6:477-482.
14. Geleff S, Schoppmann SF, Oberhuber G. Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Arch 2003;3:231-237. (Pubitemid 36399216)
15. Giudice LC, Kao LC. Endometriosis. Lancet 2004;9447:1789-1799. (Pubitemid 39488065)
16. Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2005;23:8364-8371. (Pubitemid 41746949)
17. Hong YK, Harvey N, Noh YH, Schacht V, Hirakawa S, Detmar M, Oliver G. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 2002;3:351-357. (Pubitemid 35265813)
18. Kajiya K, Hirakawa S, Detmar M. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am J Pathol 2006;4:1496-1503. (Pubitemid 351194380)
19. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000;49:5598-5605.
20. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004; 1:74-80. (Pubitemid 38081471)
21. Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, Masuzaki H. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod 2010;3:642-653.
22. Kubo H, Cao R, Brakenhielm E, Makinen T, Cao Y, Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA 2002;13:8868-8873. (Pubitemid 34693650)
23. Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P, Lin C, Fiebiger E, Wei X, Wu Y et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 2004;4:1048-1057. (Pubitemid 39038025)
24. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 2009; 4:529-538.
25. Lorente Poyatos R, Palacios Perez A, Bravo Bravo F, Lopez Caballero FJ, Bouhmidi A, Huertas Nadal C, Ruiz Escolano E. Rectosigmoid endometriosis with lymph node involvement. Gastroenterol Hepatol 2003;1:23-25. (Pubitemid 36168872)
26. Mangler M, Loddenkemper C, Lanowska M, Bartley J, Schneider A, Kohler C. Histopathology-based combined surgical approach to rectovaginal endometriosis. Int J Gynaecol Obstet 2008;1:59-64.
27. Mechsner S, Weichbrodt M, Riedlinger WF, Bartley J, Kaufmann AM, Schneider A, Kohler C. Estrogen and progestogen receptor positive endometriotic lesions and disseminated cells in pelvic sentinel lymph nodes of patients with deep infiltrating rectovaginal endometriosis: a pilot study. Hum Reprod 2008;10:2202-2209.
28. Mechsner S, Weichbrodt M, Riedlinger WF, Kaufmann AM, Schneider A, Kohler C. Immunohistochemical evaluation of endometriotic lesions and disseminated endometriosis-like cells in incidental lymph nodes of patients with endometriosis. Fertil Steril 2010;94:457-463.
29. Meyer R. Über den Stand der Frage der Andenomyositis und Adenomyome im allgemeinen und insbesondere über Adenomyositis seroepithelialis und Adenomyometritis sacromatosa. Zentralbl Gynakol 1919;36:754.
30. Noël JC, Chapron C, Fayt I, Anaf V. Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril 2008;5:1069-1072. (Pubitemid 351671720)
31. Oliver G. Lymphatic vasculature development. Nat Rev Immunol 2004; 1:35-45. (Pubitemid 38084130)
32. Pedica F, Ligorio C, Tonelli P, Bartolini S, Baccarini P. Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40. Virchows Arch 2008;1:57-63.
33. Petrova TV, Makinen T, Makela TP, Saarela J, Virtanen I, Ferrell RE, Finegold DN, Kerjaschki D, Yla-Herttuala S, Alitalo K. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 2002;17:4593-4599. (Pubitemid 34984346)
34. Ryan IP, Taylor RN. Endometriosis and infertility: new concepts. Obstet Gynecol Surv 1997;6:365-371. (Pubitemid 27237390)
35. Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927;2:93-110, 143.
36. Schacht V, Ramirez MI, Hong YK, Hirakawa S, Feng D, Harvey N, Williams M, Dvorak AM, Dvorak HF, Oliver G et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003;14:3546-3556. (Pubitemid 36898332)
37. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005;3:913-921. (Pubitemid 40315647)
38. Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, Gnant M, Horvat R, Jakesz R, Birner P. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 2006;6:839-846. (Pubitemid 43902914)
39. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J 2002;9:922-934. (Pubitemid 34753498)
40. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002;955:89-100; discussion 118, 396-406. (Pubitemid 34271066)
41. Thomas EJ, Campbell IG. Evidence that endometriosis behaves in a malignant manner. Gynecol Obstet Invest 2000;50(Suppl. 1):2-10.
42. Tuttlies F, Keckstein J, Ulrich U, Possover M, Schweppe KW, Wustlich M, Buchweitz O, Greb R, Kandolf O, Mangold R et al. ENZIAN-score, a classification of deep infiltrating endometriosis. Zentralbl Gynakol 2005; 5:275-281. (Pubitemid 41392324)
43. Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006;12:1611-1625. (Pubitemid 44950785)
44. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;1:1-8.
45. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;6:769-778. (Pubitemid 29446894)
46. Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark GB, Alitalo K, Tomarev SI, Niemeyer C et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002; 10:1271-1273.
47. Zanetti-Dallenbach R, Bartley J, Muller C, Schneider A, Kohler C. Combined vaginal-laparoscopic-abdominal approach for the surgical treatment of rectovaginal endometriosis with bowel resection: a comparison of this new technique with various established approaches by laparoscopy and laparotomy. Surg Endosc 2008;4:995-1001. (Pubitemid 351545764)